Extended storage of SARS-CoV-2 nasopharyngeal swabs does not negatively impact results of molecular-based testing across three clinical platforms

With the global outbreak of COVID-19, the demand for testing rapidly increased and quickly exceeded the testing capacities of many laboratories. Clinical tests which receive CE (Conformité Européenne) and Food and Drug Administration (FDA) authorisations cannot always be tested thoroughly in a real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Skalina, Karin A, Goldstein, D Y, Sulail, Jaffar, Hahm, Eunkyu, Narlieva, Momka, Szymczak, Wendy, Fox, Amy S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685649/
https://www.ncbi.nlm.nih.gov/pubmed/33144357
http://dx.doi.org/10.1136/jclinpath-2020-206738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685649/
https://www.ncbi.nlm.nih.gov/pubmed/33144357
http://dx.doi.org/10.1136/jclinpath-2020-206738

Ejemplares similares